• Contact Us
PAVmed Inc. - Innovating at the speed of life. PAVmed Inc. - Innovating at the speed of life.
  • Home
  • Company
    • About Us
    • Business Model
    • Leadership
    • Board of Directors
    • Medical Advisory Board
    • Careers
  • Products
    • EsoCheck
    • EsoGuard
    • CarpX
    • PortIO
    • DisappEAR
    • Future Innovations
  • Investor Relations
  • Contact
PAVmed Inc. - Innovating at the speed of life.
  • Home
  • Company
    • About Us
    • Business Model
    • Leadership
    • Board of Directors
    • Medical Advisory Board
    • Careers
  • Products
    • EsoCheck
    • EsoGuard
    • CarpX
    • PortIO
    • DisappEAR
    • Future Innovations
  • Investor Relations
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • NASDAQ: PAVM
    • NASDAQ: PAVMZ
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts

PAVmed Subsidiary Lucid Diagnostics Receives CE Mark Certification for its EsoCheck® Esophageal Cell Collection Device

May 26, 2021 9:30am EDT

PAVmed Receives European CE Mark Certification for its CarpX® Minimally Invasive Carpal Tunnel Device

May 25, 2021 9:30am EDT

Data Presented at Digestive Disease Week 2021 Support Clinical Utility of PAVmed Subsidiary Lucid Diagnostics’ EsoCheck and EsoGuard Technologies

May 24, 2021 9:30am EDT

PAVmed Provides Business Update and First Quarter 2021 Financial Results

May 17, 2021 4:00pm EDT

PAVmed Subsidiary Lucid Diagnostics Announces Upcoming Presentation at Digestive Disease Week 2021

May 13, 2021 9:30am EDT

PAVmed Subsidiary Lucid Diagnostics Expands Commercial Leadership Team

May 06, 2021 9:30am EDT

PAVmed to Hold Business Update Conference Call on May 17, 2021

May 03, 2021 9:30am EDT

Dr. Jacque Sokolov Joins PAVmed Subsidiary Lucid Diagnostics’ Board of Directors

Apr 29, 2021 9:30am EDT

Global Industry Executive Debbie White Joins PAVmed Board of Directors

Apr 27, 2021 9:30am EDT

PAVmed Chairman & CEO Lishan Aklog, M.D. named Top 50 Healthcare Technology CEO by Healthcare Technology Report

Apr 15, 2021 9:30am EDT
RSS
  • Prev
    • 1...
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • ...23
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

    About PAVmed Inc.

    PAVmed Inc. (Nasdaq:PAVM) is a highly-differentiated, multi-product medical device company employing a unique and proven business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. This model enables us to pursue an expanding pipeline strategy with a view to enhancing and accelerating value creation.

    Follow Us

    PAVmed Inc

    One Grand Central Place, Suite 4600
    New York, NY 10165
    212-949-4319
    info@pavmed.com


    PAVmed Inc. - Innovating at the speed of life.
    © Copyright 2023. All Rights Reserved by PAVmed Inc. .
    • News
    • Contact
    • Privacy Policy
    For more information regarding the proposed terms of settlement of a pending class action lawsuit, please click here.